Advanced Search

 

Study ID Status Title Patient Level Data
PROB2004 Completed A Phase II Trial to Assess the Preliminary Antiviral Effect, Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of APV Oral Solution in Combination with NRTIs in HIV Infected Children Below 13 Years Old
PROF3002 Completed Open label pilot study to evaluate the effect of antiretroviral drugs on HIV-1 in different compartments (plasma and lymphoid tissues).
R1810198 Completed An actual use study in support of the over-the-counter switch of Flonase Allergy
R1810220 Completed An efficacy and safety study of fluticasone propionate (FP) aqueous nasal spray in subjects with perennial allergic rhinitis (PAR)
R1810221 Completed An efficacy and safety study of fluticasone propionate (FP) aqueous nasal spray in subjects with seasonal allergic rhinitis (SAR)
RA1100849 Completed A randomised, parallel group, placebo-controlled, double blind study to assess the safety and tolerability of SB-681323 at 7.5mg daily dose for 28 days and its effect on the levels of serum C-reactive protein (CRP) in subjects with rheumatoid arthritis (RA)
RA1104046 Completed A randomised, placebo-controlled, parallel group single dose study of SB681323 in patients with active RA to investigate the CRP dose response relationship
RA3103718 Completed A randomized, double blind, placebo controlled study to investigate the safety and tolerability and clinical activity of 28 days of oral repeat dosing with GW856553 at 7.5mg BID in subjects with active rheumatoid arthritis on stable anti-rheumatic therapy.
RA3103730 Completed A randomised, placebo-controlled, parallel group single dose study of GW856553 in patients with active RA to investigate the C-Reactive Protein (CRP) dose response relationship
RA4104917 Completed A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety, tolerability, pharmacokinetics and effect on synovial thickness and vascularity of 28 days repeat dosing of GW274150 or 7.5mg prednisolone in RA subjects. Study Listed on ClinicalStudyDataRequest.com
RD 32/20370A H34(105)-121-V Completed Comparative bioavailability of 25mg and 100mg blackcurrant flavoured, dispersible lamotrigine tablets with 100mg lamotrigine capsules.
RD 32/20370B H34(105)-120-V Completed Comparative bioavailability of 5mg and 25mg black currant flavoured, dispersible lamotrigine tablets with 25mg lamotrigine capsules.
RES100767 Terminated A Study To Validate Key Therapeutic Targets and Characterise Their Response to Corticosteroids in Multiple Asthma Phenotypes
RES100769 Terminated A study to assess disease pathology and key therapeutic targets in severe asthma
RES104031 Completed A Randomised (with Respect to Microplaque Treatment Positions), Single-Blind, Placebo-Controlled, Positive-Controlled, Microplaque Study to Assess the Effectiveness of a Topical Formulation of GW786034 in Patients with Chronic Plaque Psoriasis
RES10983 Completed Double blind, randomised, placebo controlled, three periods, crossover study to investigate in a 72 hours enforced smoking cessation severity of withdrawal symptoms and craving in healthy volunteers on Zyban.
RES10988 Completed A randomised, double-blind, triple-dummy, placebo-controlled, five-way cross-over study to investigate the bronchodilatory effects of single doses of salmeterol (25, 50 and 200 mg) and salbutamol (200 mg) over a 24-h period in healthy subjects. Study Listed on ClinicalStudyDataRequest.com
RES11070 Completed A randomised, double-blind, triple-dummy, placebo-controlled, five-way crossover study to investigate the bronchoprotective effects against methacholine challenge and the bronchodilatory effects of single doses of salmeterol (25, 50 and 200 µg) and salbutamol (200 µg) over a 24-hour period in atopic non-asthmatic subjects. Study Listed on ClinicalStudyDataRequest.com
RES11078 500K Affymetric Whole genome scan Completed Multi-Site Collaborative Study for Genotype-Phenotype Associations in Alzheimers disease - GenADA
RES11098 Completed A Randomized, Single-Blind, Placebo-Controlled, Parallel Group, Exploratory Research Study to Describe the Pharmacodynamic Effects of Glyburide, Metformin, and Rosiglitazone versus Placebo for 8 Weeks in Adult Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
RES20044 Completed A double-blind, randomised, single dose, placebo-controlled, crossover design to investigate the efficacy of a new chemical entity (NCE) administered intravenously and subcutaneous sumatriptan in acute migraine.
RES41059 Completed The dose dependent effects of fluticasone propionate on airway responsiveness to adenosine-5-monophopshate (AMP) in mild asthmatic patients.
RES41092 Completed A comparative study of the bronchoprotective effect of single dose inhaled glucocorticosteroid against adenosine 5'-monophosphate (AMP) challenge in mild asthma.
RES41102 Completed A time-course study of the bronchoprotective effect of single dose inhaled fluticasone propionate 250 mg against adenosine 5’-monophosphate (AMP) challenge in mild asthma.
RH01299 Completed The Effect of Fluoride in an Experimental Dentifrice on Remineralization of Erosive Lesions In-Situ

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.